Skip to main content
. Author manuscript; available in PMC: 2015 Jan 8.
Published in final edited form as: J Orthop Sports Phys Ther. 2012 Oct 22;42(12):1039–1049. doi: 10.2519/jospt.2012.3763

TABLE 1.

Subject Information for Aim 1 (n = 13)*

3 mo 1 y 3 y
Height, m 1.72 ± 0.08
Weight, kg 91.9 ± 10.6 91.1 ± 10.9 89.9 ± 10.9
BMI, kg/m2 31.0 ± 4.1 30.8 ± 4.2 30.4 ± 4.0
SF-36 PCS 45.2 ± 8.0 52.2 ± 4.4 46.0 ± 8.7
SF-36 MCS 58.0 ± 5.3 58.2 ± 4.4 56.9 ± 4.2
KOS-ADL 0.81 ± 0.10 0.88 ± 0.09 0.88 ± 0.09
TUG, s 7.4 ± 1.3 6.9 ± 1.4 7.0 ± 11.3
SCT, s 11.3 ± 3.0 10.1 ± 2.3 10.2 ± 2.1
6MW, m 581.1 ± 109.5 580.2 ± 172.8 615.2 ± 113.8
Knee e-AROM, deg§ 1.6 ± 2.4 –0.2 ± 3.4 –2.1 ± 3.7
Knee f-AROM, deg 119.5 ± 8.9 124.7 ± 6.9 128.5 ± 8.3
MVIC, N/BMI
  Operated 18.4 ± 7.4 21.2 ± 9.2 19.8 ± 7.5
  Nonoperated 27.8 ± 9.7 25.9 ± 11.2 21.5 ± 9.8
CAR, %
  Operated 92.5 ± 4.7 93.2 ± 7.1 90.6 ± 9.8
  Nonoperated 92.2 ± 6.2 90.4 ± 6.5 89.0 ± 8.8

Abbreviations: 6MW, 6-minute walk test; BMI, body mass index; CAR, central activation ratio; e-AROM, extension active range of motion; f-AROM, flexion active range of motion; KOS-ADL, Knee Outcome Survey activities of daily living subscale; MCS, mental component summary; MVIC, maximum voluntary isometric contraction; PCS, physical component summary; SCT, stair-climbing test; SF-36, Medical Outcomes Study 36-Item Short-Form Health Survey; TUG, timed up-and-go test.

*

Values are mean ± SD.

Significant difference from the previous session (P<.01).

Significant difference from the previous session (P<.05).

§

Negative direction of e-AROM indicates hyperextension of the knee.

Significant difference from the nonoperated limb (P<.01).

Significant difference from the nonoperated limb (P<.05).